Literature DB >> 3196318

Purification of the human erythrocyte nucleoside transporter by immunoaffinity chromatography.

F Y Kwong1, A Davies, C M Tse, J D Young, P J Henderson, S A Baldwin.   

Abstract

The nucleoside transporter has been purified by passage of a preparation of human erythrocyte-membrane band-4.5 proteins through a column of immobilized antibodies specific for the glucose transporter. This procedure removed greater than 99.8% of the glucose transporters and achieved an approx. 18-fold purification of the nucleoside transporter, constituting a 478-fold purification from erythrocyte membranes. The isolated protein migrated as a single broad band of average apparent Mr 55,000 on SDS/polyacrylamide gels and bound approx. 0.6 mol of nitrobenzylthioinosine/mol of polypeptide, with a Kd of 1.1 +/- 0.14 (S.E.M.) nM. Upon reconstitution into large unilamellar phospholipid vesicles it catalysed the uptake of uridine with an apparent specific activity 6-fold greater than that of the unfractionated band-4.5 proteins. Furthermore, the purified nucleoside transporter was not labelled on Western blots by monoclonal antibody raised against the glucose transporter. It is concluded that the nucleoside transporter has been purified to near homogeneity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196318      PMCID: PMC1135216     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Reconstitution and purification of the D-glucose transporter from human erythrocytes.

Authors:  M Kasahara; P C Hinkle
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

Review 5.  Nucleoside transport in animal cells.

Authors:  J D Young; S M Jarvis
Journal:  Biosci Rep       Date:  1983-04       Impact factor: 3.840

6.  Monosaccharide transporter of the human erythrocyte. Characterization of an improved preparation.

Authors:  S A Baldwin; J M Baldwin; G E Lienhard
Journal:  Biochemistry       Date:  1982-08-03       Impact factor: 3.162

7.  The monosaccharide transport system of the human erythrocyte. Solubilization and characterization on the basis of cytochalasin B binding.

Authors:  M A Zoccoli; S A Baldwin; G E Lienhard
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

8.  A one-step purification of membrane proteins using a high efficiency immunomatrix.

Authors:  C Schneider; R A Newman; D R Sutherland; U Asser; M F Greaves
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

Review 9.  Transport of nucleoside drugs in animal cells.

Authors:  A R Paterson; N Kolassa; C E Cass
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

10.  Extraction and partial purification of the nucleoside-transport system from human erythrocytes based on the assay of nitrobenzylthioinosine-binding activity.

Authors:  S M Jarvis; J D Young
Journal:  Biochem J       Date:  1981-01-15       Impact factor: 3.857

View more
  8 in total

1.  5'-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), a novel ligand with high affinity for polypeptides associated with nucleoside transport. Partial purification of the nitrobenzylthioinosine-binding protein of pig erythrocytes by affinity chromatography.

Authors:  F R Agbanyo; D Vijayalakshmi; J D Craik; W P Gati; D P McAdam; J Asakura; M J Robins; A R Paterson; C E Cass
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

2.  Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).

Authors:  M F Vickers; R S Mani; M Sundaram; D L Hogue; J D Young; S A Baldwin; C E Cass
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

3.  Effects of transformation by v-fps on nucleoside transport in Rat-2 fibroblasts.

Authors:  K A Meckling-Gill; C E Cass
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

4.  Functional expression of the nitrobenzylthioinosine-sensitive nucleoside transporter of human choriocarcinoma (BeWo) cells in isolated oocytes of Xenopus laevis.

Authors:  C E Boumah; C M Harvey; A R Paterson; S A Baldwin; J D Young; C E Cass
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

5.  Glycation of the human erythrocyte glucose transporter in vitro and its functional consequences.

Authors:  P J Bilan; A Klip
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

6.  Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast.

Authors:  L F Barros; J C Bustamante; D L Yudilevich; S M Jarvis
Journal:  J Membr Biol       Date:  1991-01       Impact factor: 1.843

7.  Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells.

Authors:  C E Boumah; D L Hogue; C E Cass
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

8.  A new fluorescent probe for the equilibrative inhibitor-sensitive nucleoside transporter. 5'-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5'-thioadenosine (SAENTA)-chi 2-fluorescein.

Authors:  J S Wiley; A M Brocklebank; M B Snook; G P Jamieson; W H Sawyer; J D Craik; C E Cass; M J Robins; D P McAdam; A R Paterson
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.